These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10402244)
1. Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review). Toma S; Ugolini D; Palumbo R Int J Oncol; 1999 Aug; 15(2):321-37. PubMed ID: 10402244 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis. Beguerie JR; Xingzhong J; Valdez RP Int J Dermatol; 2010 Oct; 49(10):1194-202. PubMed ID: 20883410 [TBL] [Abstract][Full Text] [Related]
3. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. McClay EF; Albright KD; Jones JA; Christen RD; Howell SB Cancer Res; 1993 Apr; 53(7):1571-6. PubMed ID: 8453625 [TBL] [Abstract][Full Text] [Related]
5. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma. Flaherty LE Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653 [TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials. Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for metastatic melanoma. Mandarà M; Nortilli R; Sava T; Cetto GL Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649 [TBL] [Abstract][Full Text] [Related]
8. Chemohormonal therapy for malignant melanomas of the nasal and paranasal mucosa. Seo W; Ogasawara H; Sakagami M Rhinology; 1997 Mar; 35(1):19-21. PubMed ID: 9200258 [TBL] [Abstract][Full Text] [Related]
9. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640 [TBL] [Abstract][Full Text] [Related]
10. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer]. Hoeller U; Borgmann K; Feyer P; Souchon R; Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084 [TBL] [Abstract][Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
13. Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin. McClay EF; Jones JA; Winski PJ; Albright KD; Christen RD; Howell SB Cancer Res; 1996 Sep; 56(17):3993-7. PubMed ID: 8752169 [TBL] [Abstract][Full Text] [Related]
14. Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results. Egberts F; Kahler KC; Livingstone E; Hauschild A Onkologie; 2008 Jul; 31(7):398-403. PubMed ID: 18596389 [TBL] [Abstract][Full Text] [Related]
16. Enhancing the efficacy of hormonal agents with selected targeted agents. Johnston SR Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S28-36. PubMed ID: 19561004 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Müllauer L; Grasl-Kraupp B; Bursch W; Schulte-Hermann R Hepatology; 1996 Apr; 23(4):840-7. PubMed ID: 8666340 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. Gelmann EP Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-65-S1-70. PubMed ID: 9045318 [TBL] [Abstract][Full Text] [Related]
19. Modulation of cisplatin resistance in human malignant melanoma cells. McClay EF; Albright KD; Jones JA; Eastman A; Christen R; Howell SB Cancer Res; 1992 Dec; 52(24):6790-6. PubMed ID: 1458467 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen: is it useful in the treatment of patients with metastatic melanoma? McClay EF; McClay ME J Clin Oncol; 1994 Mar; 12(3):617-26. PubMed ID: 8120562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]